FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

716046009: Mepolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3304563013 Mepolizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3304564019 Mepolizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mepolizumab Is a Substance with interleukin 5 receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Mepolizumab Has disposition Interleukin receptor antagonist false Inferred relationship Existential restriction modifier
Mepolizumab Has disposition Interleukin 5 receptor antagonist true Inferred relationship Existential restriction modifier
Mepolizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing mepolizumab (medicinal product) Has active ingredient True Mepolizumab Inferred relationship Existential restriction modifier 1
Product containing only mepolizumab in parenteral dose form (medicinal product form) Has active ingredient True Mepolizumab Inferred relationship Existential restriction modifier 1
Mepolizumab Has active ingredient True Mepolizumab Inferred relationship Existential restriction modifier 1
Product containing mepolizumab in parenteral dose form (medicinal product form) Has active ingredient True Mepolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely mepolizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Mepolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely mepolizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Mepolizumab Inferred relationship Existential restriction modifier 1
Mepolizumab 100mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 100mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg/1ml solution for injection pre-filled syringes (GlaxoSmithKline UK Ltd) Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg/1ml solution for injection pre-filled syringes (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 40mg/0.4ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 40mg/0.4ml solution for injection pre-filled syringes (GlaxoSmithKline UK Ltd) Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 40mg/0.4ml solution for injection pre-filled syringes (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials 1 vial Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) 1 vial Has specific active ingredient True Mepolizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start